semaglutide anesthesia considerations Anesthetic for Patients Taking Glucagon-Like Peptide-1 Agonists PDF) Glucagon-Like Peptide-1 Agonists and

A comprehensive cardiovascular assessment should form part of the pre-treatment evaluation

10.1016/j.freeradbiomed.2010.04.036 52 KseibatiM

Surrogate Cardiometabolic Endpoints RCTs consistently demonstrate that combined SGLT2i and GLP-1RA therapy provides benefits in glycemic control, body weight, and blood pressure compared with either medication alone

KEY TAKEAWAYS Protein is non-negotiable: 80-100g daily prevents muscle loss (every successful participant hit this target) Cold foods during weeks 6-8: 35-40% reduction in nausea compared to hot meals Small frequent meals: Every 3 hours prevents blood sugar crashes and manages appetite suppression Gallbladder protection: 30-50g healthy fats daily reduces gallstone risk by 40% Hydration schedule: 64-80oz water daily, sipped between meals (not with meals) Phase-based approach: What works in week 1 fails in week 7

Archives of Environmental Health